Database Entry Point
max planck institut
informatik
mpii logo Minerva of the Max Planck Society
 

MPI-INF D3 Publications, generated: 5:51, 24 May 2019

Search the publication database

  . Return

Your search returned the following 14 documents:

  1. Mark Oette, Eugen Schulter, Michal Rosen-Zvi, Yardena Peres, Maurizio Zazzi, Anders Sonnerborg, Daniel Struck, Andre Altmann, and Rolf Kaiser
    Efficacy of antiretroviral therapy switch in HIV-infected patients: A 10-year analysis of the EuResist cohort
    Intervirology 55 (2): 160-166, 2012
  2. Glenn Lawyer, Eugen Schülter, Rolf Kaiser, Stefan Reuter, Mark Oette, and Thomas Lengauer
    Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort
    Medical Microbiology and Immunology 201 (3): 259-269, 2012
    [PDF: Download: RESINA_publication.pdf]
  3. Stefan Reuter, Mark Oette, Rolf Kaiser, Thomas Lengauer, Gerd Fätkenheuer, Jürgen Rockstroh, Heribert Knechten, and Dieter Häussinger
    Risk factors associated with older age in treatment-naive HIV-positive patients
    Intervirology 55 (2): 147-153, 2012
  4. Stefan Reuter, Mark Oette, Frank Clemens Wilhelm, Bastian Beggel, Rolf Kaiser, Melanie Balduin, Finja Schweitzer, Jens Verheyen, Ortwin Adams, Thomas Lengauer, Gerd Faetkenheuer, Herbert Pfister, and Dieter Haeussinger
    Erratum to: Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.
    Medical Microbiology and Immunology 200 (1): 51-51, 2011

  5. Eugen Schülter, Mark Oette, Melanie Balduin, Stefan Reuter, Jürgen Rockstroh, Gerd Fätkenheuer, Stefan Esser, Thomas Lengauer, Ali Agacfidan, Herbert Pfister, Rolf Kaiser, and Baki Akgul
    HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany
    Medical Microbiology and Immunology 200 (4): 219-223, 2011
  6. Saleta Sierra, Rolf Kaiser, Nadine Lübke, Alexander Thielen, Eugen Schuelter, Eva Heger, Martin Däumer, Stefan Reuter, Stefan Esser, Gerd Fätkenheuer, Herbert Pfister, Mark Oette, and Thomas Lengauer
    Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach
    Journal of Visualized Experiments 58: e3264,1-e3264,9, 2011
  7. Stefan Reuter, Mark Oette, Frank Clemens Wilhelm, Bastian Beggel, Rolf Kaiser, Melanie Balduin, Finja Schweitzer, Jens Verheyen, Ortwin Adams, Thomas Lengauer, Gerd Faetkenheuer, Herbert Pfister, and Dieter Haeussinger
    Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients
    Medical Microbiology and Immunology 200 (1): 39-49, 2011
  8. Michal Rosen-Zvi, Eugen Schülter, Andre Altmann, Saleta Sierra-Aragon, Maurizio Zazzi, Anders Sönnerborg, Mark Oette, Thomas Lengauer, and Rolf Kaiser
    Sustaining lamivudine/emtricitabine, abacavir, zidovudine or atazanavir from a previous treatment shows a clinical benefit
    In: Antiviral Therapy, Sitges, Spain, 2008, A86 p.
  9. Jens Verheyen, Elena Litau, Tobias Sing, Martin Däumer, Melanie Balduin, Mark Oette, Gerd Fätkenheuer, Jürgen K. Rockstroh, Ulrike Schuldenzucker, Daniel Hoffmann, Herbert Pfister, and Rolf Kaiser
    Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients
    Antiviral Therapy 11 (7): 879-887, 2006
  10. Tobias Sing, Valentina Svicher, Niko Beerenwinkel, Francesca Ceccherini-Silberstein, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, Mark Oette, Jürgen K. Rockstroh, Gerd Fätkenheuer, Carlo-Federico Perno, and Thomas Lengauer
    Characterization of novel HIV Drug Resistance Mutations using clustering, multidimensional scaling and SVM-based feature ranking
    In: Knowledge Discovery in Databases: PKDD 2005., Porto, Portugal, 2005, 285-296
  11. Niko Beerenwinkel, Tobias Sing, Thomas Lengauer, Jörg Rahnenführer, Kirsten Roomp, Igor Savenkov, Roman Fischer, Daniel Hoffmann, Joachim Selbig, Klaus Korn, Hauke Walter, Thomas Berg, Patrick Braun, Gerd Fätkenheuer, Mark Oette, Jürgen Rockstroh, Bernd Kupfer, Rolf Kaiser, and Martin Däumer
    Computational methods for the design of effective therapies against drug resistant HIV strains
    Bioinformatics 21 (21): 3943-3950, 2005
  12. Melanie Balduin, Niko Beerenwinkel, Saleta Sierra, Martin Däumer, Jürgen Rockstroh, Mark Oette, Gerd Fätkenheuer, Bernd Kupfer, Daniel Hoffmann, Joachim Selbig, Herbert Pfister, and Rolf Kaiser
    Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy
    J Clin Virol 34 (4): 277-287, 2005
  13. Niko Beerenwinkel, Thomas Lengauer, Martin Däumer, S. Sierra, Barbara Schmidt, Hauke Walter, Klaus Korn, Mark Oette, Gerd Fätkenheuer, J. Rockstroh, Daniel Hoffmann, Rolf Kaiser, and Joachim Selbig
    Geno2pheno is predictive of short-term virological response
    In: Proceedings from the 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scotsdale, Arizona, 2002, 74-74, paper no. 89.
  14. Niko Beerenwinkel, Martin Däumer, Mark Oette, Klaus Korn, Daniel Hoffmann, Rolf Kaiser, Thomas Lengauer, Joachim Selbig, and Hauke Walter
    Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
    Nucleic Acids Research 31 (13): 3850-3855, 2003